The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Morgan Stanley laid out a to-do list for Google's new finance chief. Here's what they want.

Discounts of as much as half on the $1,000-plus-a-month injectables are meant to induce insurers to offer coverage to workers ...

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...

Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 589.81% and ...

Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Novo Nordisk (NVO – Research Report) yesterday and set a price target of ...

Truist Financial analyst Srikripa Devarakonda assigned a Hold rating to the stock today. The company’s shares closed yesterday at $8.71.

Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month. Novo Nordisk's Wegovy Gets EU Backing to Treat ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Tandem Diabetes Care ( TNDM 4.25%) had some encouraging news to report on the regulatory front Thursday, and after it hit the ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...